Perfil
B.
Melina Cimler is currently the Director at Nanostics, Inc. She has previously worked as the Senior Director of Quality Assurance at Gen-Probe, Inc., Divisional Vice President of Regulatory Affairs at Abbott Laboratories, Manager of Product Development at Epitope, Inc., Senior Vice President of Quality & Regulatory Affairs at Beckman Coulter, Inc., Vice President of Quality & Regulatory Affairs at Illumina, Inc., and Principal at Bard Diagnostic Sciences, Inc.
Cargos activos de B. Cimler
| Empresas | Cargo | Inicio |
|---|---|---|
Nanostics, Inc.
 Nanostics, Inc. Medical SpecialtiesHealth Technology Nanostics, Inc. specializes in the development and commercialization of novel, non-invasive diagnostic tests for cancer. It offers ClarityDx, is the accurate diagnostic test to diagnose aggressive prostate cancer, and is positioned to emerge as the diagnostic tool for prostate cancer. The company was founded by John Lewis, Catalina Vasquez, Desmond Pink and Robert Paproski in 2017 and is headquartered in Edmonton, Canada. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de B. Cimler.
| Empresas | Cargo | Fin |
|---|---|---|
Epitope, Inc.
 Epitope, Inc. Medical SpecialtiesHealth Technology Epitope, Inc, operates through its subsidiaries. The company provides and develops diagnostic tests and devices for the detection of Human immunodeficiency virus (HIV) through its subsidiary. The company's products include OraSure, an oral specimen collection device and EPIblot, a serum-based Western blot confirmatory test kit. The prime customers of the company includes life insurance companies, prison systems, the military, and colleges and universities. The products are marketed in United States, Canada, Europe, Asia, Latin America and other countries. It is located in Beaverton, OR. | Corporate Officer/Principal | - |
| Bard Diagnostic Sciences, Inc. | Corporate Officer/Principal | - |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
| ILLUMINA, INC. | Consejero General | - |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ILLUMINA, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Epitope, Inc.
Epitope, Inc. Medical SpecialtiesHealth Technology Epitope, Inc, operates through its subsidiaries. The company provides and develops diagnostic tests and devices for the detection of Human immunodeficiency virus (HIV) through its subsidiary. The company's products include OraSure, an oral specimen collection device and EPIblot, a serum-based Western blot confirmatory test kit. The prime customers of the company includes life insurance companies, prison systems, the military, and colleges and universities. The products are marketed in United States, Canada, Europe, Asia, Latin America and other countries. It is located in Beaverton, OR. | Health Technology |
Beckman Coulter, Inc.
 Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Health Technology |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
| Bard Diagnostic Sciences, Inc. | |
Nanostics, Inc.
Nanostics, Inc. Medical SpecialtiesHealth Technology Nanostics, Inc. specializes in the development and commercialization of novel, non-invasive diagnostic tests for cancer. It offers ClarityDx, is the accurate diagnostic test to diagnose aggressive prostate cancer, and is positioned to emerge as the diagnostic tool for prostate cancer. The company was founded by John Lewis, Catalina Vasquez, Desmond Pink and Robert Paproski in 2017 and is headquartered in Edmonton, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- B. Cimler
